XBiotech Inc. logo

XBIT Earnings Date: Nov 11, 2026 (Estimated) — XBiotech Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $1.92
Market Cap $58.5M
P/E -1.2
52W Range $1.80 – $3.44
Next Earnings · During market hours (est.)

When is XBIT's next earnings date?

XBiotech Inc. (XBIT) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 11:00 AM ET (during market hours); the date is an estimate and has not been confirmed by the company.

How did XBIT do in its last earnings report?

In its most recent report on Aug 13, 2026 (Q2 2026), XBiotech Inc. posted EPS of -$0.22 versus the $0.03 estimate, a miss of 833.3%. Revenue was $0 against a $7.0M estimate. The stock's 1-day post-earnings move was -5.3%.

How much does XBIT stock move after earnings?

XBIT beat EPS estimates in 0 of its last 1 reported quarter. Over the last 8 reports the stock moved an average of 2.7% (up or down) in the day after earnings.

About XBiotech Inc.

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-13Q2 20260.03-0.22-833.33%$0❌ Miss-5.28%-6.10%-10.98%
2026-05-14Q1 2026—-0.18—$0—+0.00%-4.40%-6.40%
2026-03-13Q4 2025—-0.88—$0—-0.43%+3.46%+5.19%
2025-11-12Q3 2025—-0.20—$0—-5.78%-20.07%-13.27%
2025-08-13Q2 2025—-0.06—$0—+5.72%+8.08%-5.05%
2025-03-18Q4 2024—-0.34—$0—+1.75%-3.51%-13.45%
2024-11-13Q3 2024—-0.16—$0—-1.83%-8.59%-2.11%
2024-08-12Q2 2024—-0.43—$0—-0.76%-7.89%+0.91%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .